Evidence map›Paper›PMID 41369343›Full record

ArticleCells2025

Sustained EGFR Signaling Expands Otx2

Sanja Ivkovic, Tamara Major, Miroslav Adzic

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sanja IvkovicVinca, Institute of Nuclear Sciences, University of Belgrade, Mike Petrovica Alasa 12-14, 11001 Belgrade, Serbia.ORCID 0000-0002-7977-3166
Tamara MajorIndependent Researcher, 11221 Beograd, Serbia.
Miroslav AdzicVinca, Institute of Nuclear Sciences, University of Belgrade, Mike Petrovica Alasa 12-14, 11001 Belgrade, Serbia.ORCID 0000-0003-4234-7275

Funding

Marie Currie fellowship Welcome II (DFRH/WIIA/72/2011)Ministry of Science and Technological Development and Innovation, Republic of Serbia 451-03-136/2025-03/200017
6 · The paper itself

Abstract

The regenerative potential of the mammalian retina is limited, yet identifying signaling pathways that influence progenitor cell behavior remains an important step toward understanding the mechanisms of retinal development and plasticity. Epidermal Growth Factor Receptor (EGFR) signaling has been implicated in regulating proliferation and differentiation in the central nervous system, but its role in the postnatal retina is less defined. In this study, we employed an ex vivo explant model of the postnatal mouse retina to investigate the effects of sustained Epidermal Growth Factor (EGF) stimulation. Our results demonstrate that EGF extends the proliferative activity of progenitors that are normally quiescent after birth. However, the sustained EGFR activation (10 ng/mL, for 7 days) in the postnatal retina not only promotes EGFR+ progenitor proliferation but also maintains co-expression of Otx2 and Chx10, revealing a distinct progenitor population, suggesting that extended EGF signaling influences lineage allocation. These findings indicate that EGFR activation can modulate both the maintenance and differentiation potential of retinal progenitors in a context-dependent manner. While additional studies are needed to determine whether these progenitors develop into mature, functional neurons, our work provides a framework for future investigations into signaling pathways that may be leveraged to influence retinal development and plasticity.

Indexed as

ErbB ReceptorsHomeodomain ProteinsOtx Transcription FactorsRetinaSignal TransductionStem CellsTranscription FactorsAnimalsCell DifferentiationCell ProliferationEpidermal Growth FactorMiceMice, Inbred C57BLEGFR protein, mouseEpidermal Growth FactorErbB ReceptorsHomeodomain ProteinsOtx2 protein, mouseOtx Transcription FactorsTranscription Factorsbipolar cellsChx10EGFRepidermal growth factor (EGF)Otx2photoreceptorspostnatal retinaproliferationretinal explantsretinal progenitors

Identifiers

PMID41369343
PMCPMC12691212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.